(Q71987725)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8000982%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

Fluoxetine and selegiline--lack of significant interaction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8000982%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference

C H Waters

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8000982%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

publication date

1 August 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8000982%20AND%20SRC:MED&resulttype=core&format=json

Canadian Journal of Neurological Sciences

22 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8000982%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8000982%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8000982%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

259-261

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8000982%20AND%20SRC:MED&resulttype=core&format=json

Altered serotonin metabolism in depressed patients with parkinson's disease.

22 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS031716710004124X

7 January 2021

Fluoxetine and extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1017%2FS031716710004124X

7 January 2021

Pseudophaeochromocytoma in parkinsonian patient treated with fluoxetine plus selegiline.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710004124X

7 January 2021

Possible interactions between deprenyl and prozac.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710004124X

7 January 2021

Danger of MAOI therapy after fluoxetine withdrawal

1 reference

https://api.crossref.org/works/10.1017%2FS031716710004124X

7 January 2021

Increase of Parkinson disability after fluoxetine medication

1 reference

https://api.crossref.org/works/10.1017%2FS031716710004124X

7 January 2021

Tyramine kinetics and pressor sensitivity during monoamine oxidase inhibition by selegiline.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710004124X

7 January 2021

Parkinsonism: onset, progression, and mortality

1 reference

https://api.crossref.org/works/10.1017%2FS031716710004124X

7 January 2021

Serotonergic dysfunction in depression associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710004124X

7 January 2021

The possible mechanisms of action of (-)deprenyl in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710004124X

7 January 2021

Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors

1 reference

https://api.crossref.org/works/10.1017%2FS031716710004124X

7 January 2021

https://api.crossref.org/works/10.1017%2FS031716710004124X

1 reference

7 January 2021

Depression and Parkinson's disease: a review

1 reference

https://api.crossref.org/works/10.1017%2FS031716710004124X

7 January 2021

10.1017/S031716710004124X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8000982%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference